Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1998 1
2002 1
2005 2
2008 2
2009 2
2012 3
2013 3
2014 2
2016 3
2017 3
2018 2
2019 1
2020 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Hermansky-Pudlak syndrome: Mutation update.
Huizing M, Malicdan MCV, Wang JA, Pri-Chen H, Hess RA, Fischer R, O'Brien KJ, Merideth MA, Gahl WA, Gochuico BR. Huizing M, et al. Hum Mutat. 2020 Mar;41(3):543-580. doi: 10.1002/humu.23968. Epub 2020 Jan 23. Hum Mutat. 2020. PMID: 31898847 Free PMC article.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Savion N, Izigov N, Morein M, Pri-Chen S, Kotev-Emeth S. Savion N, et al. Neurosci Lett. 2014 Nov 7;583:108-13. doi: 10.1016/j.neulet.2014.09.034. Epub 2014 Sep 26. Neurosci Lett. 2014. PMID: 25263785
Oxidative stress and/or low cellular glutathione are associated with development and progression of neurodegenerative diseases. We have shown that S-allylmercapto-N-acetylcysteine (ASSNAC) up-regulates the level of glutathione and phase II detoxifying enzymes in cultured v …
Oxidative stress and/or low cellular glutathione are associated with development and progression of neurodegenerative diseases. We have show …
NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target.
Shukrun R, Golan H, Caspi R, Pode-Shakked N, Pleniceanu O, Vax E, Bar-Lev DD, Pri-Chen S, Jacob-Hirsch J, Schiby G, Harari-Steinberg O, Mark-Danieli M, Dekel B, Toren A. Shukrun R, et al. Oncogenesis. 2019 Sep 2;8(9):48. doi: 10.1038/s41389-019-0156-9. Oncogenesis. 2019. PMID: 31477684 Free PMC article.
Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy.
Barel O, Malicdan MCV, Ben-Zeev B, Kandel J, Pri-Chen H, Stephen J, Castro IG, Metz J, Atawa O, Moshkovitz S, Ganelin E, Barshack I, Polak-Charcon S, Nass D, Marek-Yagel D, Amariglio N, Shalva N, Vilboux T, Ferreira C, Pode-Shakked B, Heimer G, Hoffmann C, Yardeni T, Nissenkorn A, Avivi C, Eyal E, Kol N, Glick Saar E, Wallace DC, Gahl WA, Rechavi G, Schrader M, Eckmann DM, Anikster Y. Barel O, et al. Brain. 2017 Mar 1;140(3):568-581. doi: 10.1093/brain/awx002. Brain. 2017. PMID: 28364549 Free PMC article.
Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.
Shukrun R, Pode-Shakked N, Pleniceanu O, Omer D, Vax E, Peer E, Pri-Chen S, Jacob J, Hu Q, Harari-Steinberg O, Huff V, Dekel B. Shukrun R, et al. Stem Cell Reports. 2014 Jun 26;3(1):24-33. doi: 10.1016/j.stemcr.2014.05.013. eCollection 2014 Jul 8. Stem Cell Reports. 2014. PMID: 25068119 Free PMC article.
In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example.
Golan H, Shukrun R, Caspi R, Vax E, Pode-Shakked N, Goldberg S, Pleniceanu O, Bar-Lev DD, Mark-Danieli M, Pri-Chen S, Jacob-Hirsch J, Kanter I, Trink A, Schiby G, Bilik R, Kalisky T, Harari-Steinberg O, Toren A, Dekel B. Golan H, et al. Stem Cell Reports. 2018 Sep 11;11(3):795-810. doi: 10.1016/j.stemcr.2018.07.010. Epub 2018 Aug 16. Stem Cell Reports. 2018. PMID: 30122444 Free PMC article.
28 results